LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases

Overview of attention for article published in Frontiers in Pharmacology, November 2022

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 6,441 followers.

We've detected a paper from Frontiers in Pharmacology that cites a retracted paper post-retraction. Citing paper: https://t.co/55IiN2a2Wm Retracted paper: https://t.co/8Jb91Wnnfw

We've detected a paper from Frontiers in Pharmacology that cites a retracted paper post-retraction. Citing paper: https://t.co/55IiN2a2Wm Retracted paper: https://t.co/ZO00YE3eOy

New Research: LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases https://t.co/NBH7qqYg4Q #pharmacology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.